Dual Bronchodilation With Qva149 Reduces COPD Exacerbations: The Spark Study

被引：0
|
作者：
Wedzicha, J. A. [1 ]
Decramer, M. [2 ]
Ficker, J. [3 ]
Taylor, A. Fowler [4 ]
D'Andrea, P. [4 ]
Arrasate, C. [4 ]
Berhane, I. [4 ]
Chen, H. [4 ]
Banerji, D. [4 ]
机构：
[1] UCL, London, England
[2] Katolik Univ Leuven, Leuven, Belgium
[3] Klinikum Nuernberg, Nurnberg, Germany
[4] Novartis Pharmaceut, E Hanover, NJ USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2428
引用
收藏
页数：2
相关论文
共 50 条
  • [1] DUAL BRONCHODILATION WITH QVA149 REDUCES COPD EXACERBATIONS: RESULTS FROM THE IGNITE PROGRAM
    Banerji, Donald
    Fedele, Mark J.
    Chen, Hungta
    Kim, Han-Joo
    RESPIROLOGY, 2013, 18 : 70 - 70
  • [2] Once-Daily Dual Bronchodilation With QVA149 Reduces COPD Exacerbations: Results From the IGNITE Program
    Banerji, Donald
    Fedele, Mark
    Chen, Hungta
    CHEST, 2014, 145 (03)
  • [3] Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study
    Mahler, Donald A.
    Decramer, Marc
    D'Urzo, Anthony
    Worth, Heinrich
    White, Tracy
    Alagappan, Vijay K. T.
    Chen, Hungta
    Gallagher, Nicola
    Kulich, Karoly
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (06) : 1599 - 1609
  • [4] Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: The ENLIGHTEN study
    Dahl, Ronald
    Chapman, Kenneth R.
    Rudolf, Michael
    Mehta, Rajendra
    Kho, Pearl
    Alagappan, Vijay K. T.
    Chen, Hungta
    Banerji, Donald
    RESPIRATORY MEDICINE, 2013, 107 (10) : 1558 - 1567
  • [5] Dual bronchodilation with once-daily QVA149 improves lung function and reduces exacerbations in patients with COPD: The IGNITE trials
    Banerji, Donald
    Alagappan, Vijay
    Green, Yulia
    Gallagher, Nicola
    FowlerTaylor, Angel
    D'Andrea, Peter
    Chen, Hungta
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [6] QVA149 reduces COPD exacerbation rate in various subgroups of patients: The SPARK study
    Ficker, Joachim H.
    Wedzicha, Jadwiga A.
    Decramer, Marc
    FowlerTaylor, Angel
    D'Andrea, Peter
    Arrasate, Christie
    Chen, Hungta
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [7] Dual bronchodilation with QVA149 versus single bronchoditator therapy: the SHINE study
    Bateman, Eric D.
    Ferguson, Gary T.
    Barnes, Neil
    Gallagher, Nicola
    Green, Yulia
    Henley, Michelle
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (06) : 1484 - 1494
  • [8] Dual Bronchodilation With Once-Daily QVA149 Reduces Exacerbations, Improves Lung Function and Health Status Versus Glycopyrronium and Tiotropium in Severe-to-Very Severe COPD Patients: The SPARK Study
    Wedzicha, Jadwiga
    Ficker, Joachim
    Niewohner, Dennis
    Sandstroem, Thomas
    FowlerTaylor, Angel
    Banerji, Donald
    CHEST, 2014, 145 (03)
  • [9] Dual bronchodilation with once-daily QVA149 reduces exacerbations, improves lung function and health status versus glycopyrronium and tiotropium in severe-to-very severe COPD patients: The SPARK study
    Wedzicha, Jadwiga A.
    Decramer, Marc
    Ficker, Joachim H.
    Niewohner, Dennis
    Sandstrom, Thomas
    Fowler, Angel
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [10] DUAL BRONCHODILATION WITH QVA149 IN PATIENTS WITH MODERATE-TO-SEVERE COPD: IGNITE TRIALS OVERVIEW
    Mezzi, Karen
    Fedele, Mark J.
    Chen, Hungta
    Banerji, Donald
    RESPIROLOGY, 2013, 18 : 69 - 69
12345